| Basics |
|
Turnstone Biologics Corp.
|
| IPO Date: |
July 21, 2023 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$8.21M |
| Activated in VL: |
False |
| Average Daily Range |
| Avg Daily Range: |
$0.16 | 5.69%
|
| Avg Daily Range (30 D): |
$0.01 | 1.85%
|
| Avg Daily Range (90 D): |
$0.01 | 3.91%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.15M |
| Avg Daily Volume (30 D): |
.08M |
| Avg Daily Volume (90 D): |
.23M |
| Trade Size |
| Avg Trade Size (Sh.): |
214 |
| Avg Trade Size (Sh.) (30 D): |
878 |
| Avg Trade Size (Sh.) (90 D): |
465 |
| Institutional Trades |
| Total Inst.Trades: |
7 |
| Avg Inst. Trade: |
$1.99M |
| Avg Inst. Trade (30 D): |
$3.06M |
| Avg Inst. Trade (90 D): |
$3.06M |
| Avg Inst. Trade Volume: |
.5M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.99M |
| Avg Closing Trade (30 D): |
$3.06M |
| Avg Closing Trade (90 D): |
$3.06M |
| Avg Closing Volume: |
594.06K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$-2.04
|
$-.24
|
$-.51
|
|
Diluted EPS
|
$-2.04
|
$-.24
|
$-.51
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -47.2M
|
$ -5.49M
|
$ -11.81M
|
|
Operating Income / Loss
|
$ -44.47M
|
$ -5.56M
|
$ -9.16M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 11.53M
|
$ M
|
$ M
|
|
PE Ratio
|
|
|
|
|
|
|